Videos Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Genomics ETFs have surged of late; here’s why. Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Articles You May Like Activist ValueAct is poised to trim fat and help boost profits at Meta Platforms. Here’s how Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook 5 More Trump Stocks to Trade Gary Gensler says he was ‘proud to serve’ as SEC chair, defends his approach to crypto regulation Stock-market investors cheered end of election uncertainty. Policy uncertainty remains.